Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ruiz Extremera

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Revista Espanola De Enfermedades Digestivas|July 27, 2007
[How does autoimmune hepatitis behave in children?]A Ruiz Extremera, J Salmerón
Revista Espanola De Enfermedades Digestivas|November 1, 1992
[Treatment of chronic non-A, non-B-C hepatitis]F J Salmerón Escobar, H Sánchez Martínez, A Ruiz Extremera
Medicina Clinica|May 8, 1999
[Retrospective study of the incidence of hepatitis G virus infection in transfused patients]J Salmerón, I Carmona, C Torres, et al.
Revista Espanola De Enfermedades Digestivas|April 15, 2003
Genomic and antigenomic chains of hepatitis C virus and hepatitis G virus in serum, liver and peripheral blood mononuclear cellsC Torres, P Muñoz de Rueda, A Ruiz-Extremera, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|December 7, 2007
[Hypertension and white coffee stains. Diagnosis: aorta media syndrome associated with type 1 neurofibromatosis]A Abril Molina, E Ocete Hita, A González Carretero, et al.
Liver|August 25, 1999
Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trialJ Salmerón, A Ruiz-Extremera, C Torres, et al.
Journal of Virological Methods|March 21, 1998
Determination of HCV RNA concentration by direct quantitation of the products from a single RT-PCRM Pérez-Ruiz, C Torres, P A García-López, et al.
Anales Espanoles De Pediatria|June 4, 2002
[Drug-induced hepatotoxicity in children. Where we are and where we are going]M A Peiré, M I Lucena, A Ruiz-Extremera, et al.
Colloids and Surfaces. B, Biointerfaces|June 25, 2013
Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticlesKatarzyna Rudzka, Julián L Viota, J A Muñoz-Gamez, et al.
Gastroenterologia Y Hepatologia|January 31, 1998
[Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver]M Bruguera, M Buti, M Diago, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Revista Espanola De Enfermedades Digestivas|July 27, 2007
[How does autoimmune hepatitis behave in children?]A Ruiz Extremera, J Salmerón
Revista Espanola De Enfermedades Digestivas|November 1, 1992
[Treatment of chronic non-A, non-B-C hepatitis]F J Salmerón Escobar, H Sánchez Martínez, A Ruiz Extremera
Medicina Clinica|May 8, 1999
[Retrospective study of the incidence of hepatitis G virus infection in transfused patients]J Salmerón, I Carmona, C Torres, et al.
Revista Espanola De Enfermedades Digestivas|April 15, 2003
Genomic and antigenomic chains of hepatitis C virus and hepatitis G virus in serum, liver and peripheral blood mononuclear cellsC Torres, P Muñoz de Rueda, A Ruiz-Extremera, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|December 7, 2007
[Hypertension and white coffee stains. Diagnosis: aorta media syndrome associated with type 1 neurofibromatosis]A Abril Molina, E Ocete Hita, A González Carretero, et al.
Liver|August 25, 1999
Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trialJ Salmerón, A Ruiz-Extremera, C Torres, et al.
Journal of Virological Methods|March 21, 1998
Determination of HCV RNA concentration by direct quantitation of the products from a single RT-PCRM Pérez-Ruiz, C Torres, P A García-López, et al.
Anales Espanoles De Pediatria|June 4, 2002
[Drug-induced hepatotoxicity in children. Where we are and where we are going]M A Peiré, M I Lucena, A Ruiz-Extremera, et al.
Colloids and Surfaces. B, Biointerfaces|June 25, 2013
Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticlesKatarzyna Rudzka, Julián L Viota, J A Muñoz-Gamez, et al.
Gastroenterologia Y Hepatologia|January 31, 1998
[Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver]M Bruguera, M Buti, M Diago, et al.
Pageof 6